Bronchipret pills

Bronchipret pills

Registration code:
Trade nomination of the preparation: Bronchipret pills
Drug formulation: over-encapsulated tablets.

Composition:
1 film-coated tablet, Bronchipret pills contains:
Dry extract of primrose roots (Primulae radix) (6.0-7.0:1) 60 mg.
(extraction agent: ethanol 47.4% volume in volume);
dry extract of thyme (5.9-10.0:1) 160 mg.
(extraction agent: ethanol 70% volume in volume).
Auxiliary components: dimeticone, lactose monohydrate, starch syrup, fumed silicon dioxide, microcrystal cellulose, magnesium stearate, methylhydroxypropyl cellulose, mint aromatizer, poly (1-vinyl-2-pyrrolidone), poly (1-vinyl-2-pirrolidone) with the link via open circle, poly (ethyl acrylate-methyl methacrylate) 2:1, propylene-glycol, sodium saccharin, talcum powder, hepatoflavin (Е 101), chrolophyll powder (Е 141), titanium dioxide (Е 171).

Description: round tablets of double radius form of green color with pearl surface.

Pharmacotherapeutic group: expectorant drug of vegetative origin.
Code ATX: R05CA10.

Pharmacological properties: preparation produces expectorant, anti-inflammatory, secretolytic, broncholytic effect, it is conductive to decrease of stickiness of begma and precipitation of its evacuation.

Indications for use:
it is applied as expectorant drug at the treatment of acute and chronic inflammatory diseases of the respiratory tract, which are accompanied with cough and begma (tracheitis, tracheobronchitis, bronchitis).

Contra indications: hyper sensibility to the components of the preparation, diseases of gastro-intestinal tract in the recrudescence stage, child age up to 12 years.

Application during pregnancy and breast-feeding period: it is not recommended to apply preparation during the period of pregnancy and breast-feeding.

Posology and method of administration: apply orally, adults and children elder than 12 apply 1 tablet 3 times a day before meals. Swallow the tablet without chewing it, drinking with splash of water. The average treatment course lasts 10-14 days. It is possible to prolong the course or to have repeated one only on the recommendations of the physician.

Side effects: allergic response, rarely - nausea.

Overdosage: aches in the area of stomach, vomiting, diarrhea is possible at overdosage.

Interaction with other medication: it is not recommended to apply pills Bronchipret together with antitussive preparation and also with medicaments, which decrease the development of begma, because it complicates expectoration of diluted begma. The combination with antibacterial medicine is possible.

Special remarks:
It is recommended to consult a physician, if the symptoms do not disappeared in 10-14 days. It is possible to indicate this preparation to the patients with pancreatic diabetes, because the single dosage contains less than 0,03 of considered bread units.

Form of issue: film-coated tablets. There are 20 or 25 tablets in a blister of aluminium foil (lower part) and polyvinykchloride/ polyvinyldenchloride film (upper part). There are 1 (20 tablets), 2 (by 25 tablets), 4 (by 25 tablets) or 5 (by 20 tablets) blisters together with the application instruction, they are put in folded cardboard pack.

Storage conditions: keep in dry and shadowed place, at temperature up to 25оС; keep away from children.

Expire date: 3 years. Do not use preparation if the expiry date (month and year) printed on the pack has passed.

Pharmacy purchasing terms: Without receipt.

Manufacturing enterprise:
BIONORIKA AG D-92318 Neumarkt/Germany
Kerschenstaistrasse 11-15
92318 Neumarkt 
Germany

Representative office in Moscow
119 526, Moscow, Vernadski prospect, house 105, building 2
phone. 502-90-19.


Back to the list